ClinicalTrials.Veeva

Menu

Carotid Plaque Imaging Project (CPIP)

L

Lund University

Status

Enrolling

Conditions

Atherosclerosis
Atherosclerotic Plaque

Treatments

Other: Observational study

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The rupture or erosion of an atherosclerotic plaque with thrombosis or embolization often underlie heart attacks and strokes. The early identification of patients with atherosclerotic plaques prone to rupture or erosions, vulnerable plaques (VP), and their treatment before the occurrence of events is, therefore, one of the greatest cardiovascular challenges today. Possible approaches for early detection of VP include imaging techniques allowing visualization of plaque structure, circulating biomarkers and better understanding of the pathophysiologic mechanisms of the disease. In the carotid plaque imaging project the investigators study human atherosclerotic plaques (that are removed by endarterectomy) to disclose their underlying structure and mechanisms, finding possible novel therapeutic targets or markers for VP. The investigators also study plaque structure with imaging methods and try to develop new ways to detect VP using circulating or imaging markers.

Enrollment

3,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older than 18 years old, male or female that are eligible for carotid endarterectomy due to atherosclerosis and that can provide informed consent.

Exclusion criteria

  • Patients younger than 18 years old that cannot provide informed consent; pregnant.

Trial design

3,500 participants in 1 patient group

Carotid Plaque Imaging Project (CPIP)
Treatment:
Other: Observational study

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Isabel Goncalves, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems